BIOE OTC
Bio Essence Corporation
1W: +0.0%
1M: -4.2%
3M: -32.6%
YTD: +203.3%
1Y: +114.1%
$0.18
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$2M
+485.8% ▲
5Y CAGR: +14.6%
Gross Profit
$1M
+558.0% ▲
5Y CAGR: +44.4%
Operating Income
$900K
+295.9% ▲
Net Income
$896K
+168.5% ▲
EPS (Diluted)
$0.02
+168.6% ▲
EBITDA
$900K
+157.6% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $888K | $622K | $552K | $324K | $2M |
| YoY Growth | -7.4% | -30.0% | -11.3% | -41.3% | +485.8% |
| Cost of Revenue | $590K | $293K | $274K | $107K | $469K |
| Gross Profit | $298K | $328K | $277K | $217K | $1M |
| Gross Margin | 33.6% | 52.8% | 50.3% | 67.0% | 75.3% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1M | $839K | $1M | $677K | $528K |
| Operating Expenses | $1M | $839K | $1M | $677K | $528K |
| Operating Income | -$858K | -$511K | -$789K | -$459K | $900K |
| Operating Margin | -96.6% | -82.2% | -143.1% | -141.8% | 47.4% |
| Interest Expense | $48K | $19K | $17K | $2K | $2K |
| Income Before Tax | -$644K | -$525K | -$800K | -$2M | $897K |
| Tax Expense | $3K | $2K | $2K | $800 | $800 |
| Net Income | -$648K | -$810K | -$972K | -$1M | $896K |
| Net Margin | -72.9% | -130.3% | -176.2% | -404.0% | 47.2% |
| EPS (Diluted) | $-0.02 | $-0.02 | $-0.02 | $-0.03 | $0.02 |
| EBITDA | -$560K | -$497K | -$765K | -$2M | $900K |
| Shares Outstanding | 33M | 33M | 36M | 38M | 38M |